All solvents were purchased from Fisher Scientific (Pittsburgh, PA) and used without further purification unless otherwise noted. Poly(ethylene glycol) and 8-arm amine terminated poly(ethylene glycol) were purchased from JenKem Inc. Amplex Red, Alexa Fluor 488 and Maleimide-Coumarin were purchased from Invitrogen. Silicon wafers were purchased from University Wafers (Boston, MA). All other reagents including horseradish peroxidase and glucose oxidase were purchased from Sigma-Aldrich. PEG-biotin and PEG-AO were synthesized according to literature procedures.
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Analytical Techniques
NMR spectra were recorded on Bruker Avance 500 MHz or 400 MHz spectrometers. UVVisible spectroscopy was performed with a BioMate 5 Spectrophotometer (Thermo Spectronic Instruments). Infrared spectra were obtained with a Perkin-Elmer Spectrum One instrument equipped with a universal ATR accessory.
2,5-Dioxopyrrolidin-1-yl pent-4-ynoate
To a flame dried round bottom flask containing 100 mL of freshly distilled methylene chloride (DCM) was added N-hydroxysuccinimide (NHS) (1.0 g, 8.7 mmol, 1 eq), pentynoic acid (0.94 g, 9.6 mmol, 1.1 eq), triethylamine (TEA) (1.4 g, 14 mmol, 1.6 eq), and 4-dimethylaminopyridine (DMAP) (0.11 g, 0.87 mmol, 0.1 eq). The resulting solution was stirred for 30 min before addition of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) (1.8 g, 9.6 mmol, 1.1 eq).
The reaction was stirred for 4 h at 22°C, and the solvent was removed in vacuo to give a crude product which was subjected to column chromatography (100% dichloromethane -DCM, R f 0.4). This product was further purified by recrystallization from 1 : 4 ethyl acetate : hexanes to obtain the title compound as a white solid (0.69 g, 40% yield 3304, 2948, 2258, 1815, 1787, 1734, 1430, 1415, 1371, 1203, 1085, 1067, 993, 906. 3 Figure S1 . 1 H NMR (500 MHz, CDCl 3 ) of 2,5-Dioxopyrrolidin-1-yl pent-4-ynoate
N-Hydroxy Succinimidyl Levulinate
This compound was synthesized similarly to a known procedure. 3 To a flame dried round bottom flask containing 100 mL of freshly distilled DCM was added levulinic acid (1.0 g, 8.6
mmol, 1 eq), NHS (1.1 g, 9.5 mmol, 1.1 eq), TEA (1.7 g, 17 mmol, 2 eq), and DMAP (0.11 g, 0.86 mmol, 0.1 eq). The resulting solution was cooled to 0°C and stirred for 30 min before addition of N,N'-dicyclohexylcarbodiimide (DCC) (1.8 g, 9.5 mmol, 1.1 eq). The reaction was warmed to room temperature and stirred for an additional 6 h. nm dye) with a correlation factor of 0.11.
Fabrication and Enzyme Immobilization on Control Surfaces
Cross-Reactive Surface AO-PEG (10 µL, 1wt% in MeOH) was spin coated onto a piranha cleaned silicon wafer with gold alignment marks (4000 rpm, 1 min). The wafer was then patterned by e-beam lithography as an array of 40 µm boxes (23 nm spot size, 30 kV accelerating voltage, 40 µC/cm 2 area dose).
The wafer was developed by immersion in Milli-Q water for 30 seconds, and patterns were confirmed using an inverted bright-field microscope. The wafer was subsequently spin coated 
GOX Immobilized Surface
Alkyne-PEG (10 µL, 1wt% in MeOH) was spin coated onto a piranha cleaned silicon wafer (4000 rpm, 1 min). The wafer was then patterned by e-beam lithography as an array of 40 µm boxes (23 nm spot size, 30 kV accelerating voltage, 20 µC/cm 2 area dose). The wafer was developed by immersion in Milli-Q water for 30 seconds, and patterns were confirmed using an inverted bright-field microscope. Next, Azide-GOX-AF488 (20 µL in DPBS), CuSO 4 (10 µL, 1 mg/mL), and sodium ascorbate (10 µL, 5 mg/mL) were exposed to the surface for 24 h before washing by immersion in 5 mL aliquots of 10% DMSO in DPBS 5 times for 30 seconds each.
Activity was assayed by adding the enzyme immobilized surface to a solution of HRP (1 µg), glucose (10 mM), and Amplex Red (50 µM in DMSO) in DPBS, pH 7.4 and measuring the absorbance of resorufin at 560 nm after 2 h at 4°C.
PEG-OH Control Surface
8-Arm poly(ethylene glycol) (10.9 kDa, 10 µL, 1 wt% in MeOH) was spin coated onto a piranha cleaned silicon wafer (4000 rpm, 1 min). The wafer was then patterned by e-beam lithography as an array of 40 µm boxes (23 nm spot size, 30 kV accelerating voltage, 60 µC/cm 2 area dose).
The wafer was developed by immersion in Milli-Q water for 30 seconds, and patterns were confirmed using an inverted bright-field microscope. The wafer was first exposed to Lev-HRP-MB (40 µL in DPBS), for 24 h before washing by immersion in 5 mL aliquots of DPBS, pH 7.4, 5 times for 30 seconds each. Next, Azide-GOX-AF488 (20 µL in DPBS), CuSO 4 (10 µL, 1 mg/mL), and sodium ascorbate (10 µL, 5 mg/mL) were exposed to the surface for 24 h before washing by immersion in 5 mL aliquots of 10% DMSO in DPBS 3 times for 30 seconds each.
Activity was assayed by adding the enzyme immobilized surface to a solution of HRP (1 µg), glucose (10 mM), and Amplex Red (50 µM) in DPBS, pH 7.4 and measuring the absorbance of resorufin at 560 nm after 2 h at 4°C.
Alignment Wafer Control Surface
A silicon wafer with gold alignment marks was cleaned by immersion in piranha solution. The 
